Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
64 hedge funds and large institutions have $38.9M invested in Applied Genetic Technologies Corporation in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 13 closing their positions.
290% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $379K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 71 → 64 (-7)
28% less capital invested
Capital invested by funds: $53.9M → $38.9M (-$15M)
38% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 24
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.63M |
| 2 |
Two Sigma Advisers
New York
|
+$703K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$489K |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$295K |
| 5 |
Morgan Stanley
New York
|
+$252K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.9M |
| 2 |
E
Ergoteles
New York
|
-$560K |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$474K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$386K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$384K |
AGTC Hedge Fund Activity: Q3 2021 in Review
64 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2021, worth a combined $38.9M — down 28% from $53.9M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of AGTC and 7 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 15 added.
The largest buyer was GSA Capital Partners, adding an estimated $1.63M. The largest seller was Millennium Management, cutting an estimated $1.9M.
- 64 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2021, down from 71 in Q2 2021.
- Funds reported $38.9M of Applied Genetic Technologies Corporation stock for Q3 2021, down 28% quarter-over-quarter.
- 7 funds opened new Applied Genetic Technologies Corporation positions in Q3 2021 and 13 closed out, a net change of -6 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q3 2021 was GSA Capital Partners, an estimated $1.63M added.
- The largest Applied Genetic Technologies Corporation seller in Q3 2021 was Millennium Management, an estimated $1.9M sold.
Based on aggregated 13F filings for Q3 2021.